Id |
Subject |
Object |
Predicate |
Lexical cue |
T34 |
0-21 |
Sentence |
denotes |
MATERIALS AND METHODS |
T2707 |
23-33 |
Sentence |
denotes |
Cell lines |
T35 |
23-33 |
Sentence |
denotes |
Cell lines |
T2708 |
34-290 |
Sentence |
denotes |
K-562, Jurkat and U-937 were obtained from the ATCC (American Type Culture Collection, Rockville, USA) and EM-2, LAMA-84, CML-T1, BV-173, SD-1 and RPMI-8226 from the DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany). |
T36 |
34-290 |
Sentence |
denotes |
K-562, Jurkat and U-937 were obtained from the ATCC (American Type Culture Collection, Rockville, USA) and EM-2, LAMA-84, CML-T1, BV-173, SD-1 and RPMI-8226 from the DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany). |
T2709 |
291-362 |
Sentence |
denotes |
All cell lines, except BV-173, SD-1 and RPMI-8226, were IRF-4-negative. |
T37 |
291-362 |
Sentence |
denotes |
All cell lines, except BV-173, SD-1 and RPMI-8226, were IRF-4-negative. |
T2858 |
364-392 |
Sentence |
denotes |
Cell culture and stimulation |
T38 |
364-392 |
Sentence |
denotes |
Cell culture and stimulation |
T2859 |
393-611 |
Sentence |
denotes |
All cell lines were maintained at 5% CO2 in RPMI 1640 medium with 1% glutamine (Gibco/BRL Eggenstein, Germany) supplemented with 10% fetal calf serum (Gibco/BRL), 1% penicillin/streptomycin (Biochrom, Berlin, Germany). |
T39 |
393-611 |
Sentence |
denotes |
All cell lines were maintained at 5% CO2 in RPMI 1640 medium with 1% glutamine (Gibco/BRL Eggenstein, Germany) supplemented with 10% fetal calf serum (Gibco/BRL), 1% penicillin/streptomycin (Biochrom, Berlin, Germany). |
T2860 |
612-763 |
Sentence |
denotes |
When indicated, cells were treated with 5-aza-2-deoxycytidine (AzadC) or 5-azacytidine (AzaC) (Sigma, Taufkirchen, Germany) for different time periods. |
T40 |
612-763 |
Sentence |
denotes |
When indicated, cells were treated with 5-aza-2-deoxycytidine (AzadC) or 5-azacytidine (AzaC) (Sigma, Taufkirchen, Germany) for different time periods. |
T2861 |
764-842 |
Sentence |
denotes |
Owing to their chemical instability fresh substances were re-added every 24 h. |
T41 |
764-842 |
Sentence |
denotes |
Owing to their chemical instability fresh substances were re-added every 24 h. |
T3053 |
844-876 |
Sentence |
denotes |
Sequencing of the IRF-4 promoter |
T42 |
844-876 |
Sentence |
denotes |
Sequencing of the IRF-4 promoter |
T3054 |
877-1143 |
Sentence |
denotes |
For analysis of the IRF-4 promoter region for permanent aberrations such as insertions/deletions or mutation, we PCR-amplified two fragments from genomic DNA, which was extracted from depicted cell lines with a commercial kit (Qiagen, Hilde, Germany) as recommended. |
T43 |
877-1143 |
Sentence |
denotes |
For analysis of the IRF-4 promoter region for permanent aberrations such as insertions/deletions or mutation, we PCR-amplified two fragments from genomic DNA, which was extracted from depicted cell lines with a commercial kit (Qiagen, Hilde, Germany) as recommended. |
T3055 |
1144-1171 |
Sentence |
denotes |
The primers were 1-forward: |
T44 |
1144-1171 |
Sentence |
denotes |
The primers were 1-forward: |
T3056 |
1172-1212 |
Sentence |
denotes |
5′-TTGAGATGGAGTCTTGCTCTGT-3′, 1-reverse: |
T45 |
1172-1212 |
Sentence |
denotes |
5′-TTGAGATGGAGTCTTGCTCTGT-3′, 1-reverse: |
T3057 |
1213-1254 |
Sentence |
denotes |
5′-CCAGGACCTCAGGAGGCCAGTCA-3′; 2-forward: |
T46 |
1213-1254 |
Sentence |
denotes |
5′-CCAGGACCTCAGGAGGCCAGTCA-3′; 2-forward: |
T3058 |
1255-1298 |
Sentence |
denotes |
5′-AGCGGTGAAACTGAGAGTGCGAGGT-3′, 2-reverse: |
T47 |
1255-1298 |
Sentence |
denotes |
5′-AGCGGTGAAACTGAGAGTGCGAGGT-3′, 2-reverse: |
T3059 |
1299-1326 |
Sentence |
denotes |
5′-GCCACATCGCTGCAGTTTAG-3′. |
T48 |
1299-1326 |
Sentence |
denotes |
5′-GCCACATCGCTGCAGTTTAG-3′. |
T3060 |
1327-1424 |
Sentence |
denotes |
The products were cloned with the ‘TOPO TA cloning kit’ (Invitrogen, Groningen, The Netherlands). |
T49 |
1327-1424 |
Sentence |
denotes |
The products were cloned with the ‘TOPO TA cloning kit’ (Invitrogen, Groningen, The Netherlands). |
T3061 |
1425-1679 |
Sentence |
denotes |
After bacterial amplification of the cloned PCR fragments by standard procedures, at least three clones from each sample were sequenced with an automated sequencer (ABI Prism 377, Applied Bio-systems, Foster City, USA) as recommended by the manufacturer. |
T50 |
1425-1679 |
Sentence |
denotes |
After bacterial amplification of the cloned PCR fragments by standard procedures, at least three clones from each sample were sequenced with an automated sequencer (ABI Prism 377, Applied Bio-systems, Foster City, USA) as recommended by the manufacturer. |
T3408 |
1681-1700 |
Sentence |
denotes |
Expression analysis |
T51 |
1681-1700 |
Sentence |
denotes |
Expression analysis |
T3409 |
1701-1835 |
Sentence |
denotes |
To analyze the IRF-4 transcriptional level, RNA was extracted from cells using the commercial RNAzol-kit (Paesel, Frankfurt, Germany). |
T52 |
1701-1835 |
Sentence |
denotes |
To analyze the IRF-4 transcriptional level, RNA was extracted from cells using the commercial RNAzol-kit (Paesel, Frankfurt, Germany). |
T3410 |
1836-1922 |
Sentence |
denotes |
An aliquot of 1 μg total RNA was used for cDNA synthesis as described previously (27). |
T53 |
1836-1922 |
Sentence |
denotes |
An aliquot of 1 μg total RNA was used for cDNA synthesis as described previously (27). |
T3411 |
1923-2060 |
Sentence |
denotes |
RNA expression analysis for IRF-4 and the reference gene β-actin was carried out by semi-quantitative PCR as described previously (3,27). |
T54 |
1923-2060 |
Sentence |
denotes |
RNA expression analysis for IRF-4 and the reference gene β-actin was carried out by semi-quantitative PCR as described previously (3,27). |
T3412 |
2061-2112 |
Sentence |
denotes |
PCR products were verified by automated sequencing. |
T55 |
2061-2112 |
Sentence |
denotes |
PCR products were verified by automated sequencing. |
T3413 |
2113-2259 |
Sentence |
denotes |
PCR primers and conditions for expression analysis of DNMT or MBP (DNMT1 DNMT3A, DNMT3B, MeCP, MBD1, MBD2 and MBD4) were published elsewhere (28). |
T56 |
2113-2259 |
Sentence |
denotes |
PCR primers and conditions for expression analysis of DNMT or MBP (DNMT1 DNMT3A, DNMT3B, MeCP, MBD1, MBD2 and MBD4) were published elsewhere (28). |
T3414 |
2260-2377 |
Sentence |
denotes |
For analysis of IRF-4 protein expression, a standard immunoblotting assay was performed as described previously (29). |
T57 |
2260-2377 |
Sentence |
denotes |
For analysis of IRF-4 protein expression, a standard immunoblotting assay was performed as described previously (29). |
T3415 |
2378-2668 |
Sentence |
denotes |
Briefly, protein lysates were generated by incubating 1 × 106 cells in 100 µl RIPA buffer (1% NP-40, 0.5% sodiumdesoxycholate, 0.1% SDS, 100 µg/ml phenylmethylsulfonyl fluoride, 10 µl/ml protease-inhibitory-mix, 1 µmol/ml sodiumorthovanadate in phosphate-buffered saline) for 30 min on ice. |
T58 |
2378-2668 |
Sentence |
denotes |
Briefly, protein lysates were generated by incubating 1 × 106 cells in 100 µl RIPA buffer (1% NP-40, 0.5% sodiumdesoxycholate, 0.1% SDS, 100 µg/ml phenylmethylsulfonyl fluoride, 10 µl/ml protease-inhibitory-mix, 1 µmol/ml sodiumorthovanadate in phosphate-buffered saline) for 30 min on ice. |
T3416 |
2669-2799 |
Sentence |
denotes |
After centrifugation, protein concentration of the supernatant was determined by BCA-method (Pierce, Rockford, IL) as recommended. |
T59 |
2669-2799 |
Sentence |
denotes |
After centrifugation, protein concentration of the supernatant was determined by BCA-method (Pierce, Rockford, IL) as recommended. |
T3417 |
2800-2960 |
Sentence |
denotes |
Protein lysates (70–100 µg) were electrophoresed on polyacrylamide gels and transferred to a PVDF-membrane (Immobilon P, 0.45 µm; Millipore, Eschborn, Germany). |
T60 |
2800-2960 |
Sentence |
denotes |
Protein lysates (70–100 µg) were electrophoresed on polyacrylamide gels and transferred to a PVDF-membrane (Immobilon P, 0.45 µm; Millipore, Eschborn, Germany). |
T3418 |
2961-3338 |
Sentence |
denotes |
Membranes were blocked with 2.5% blocking reagent (Boehringer Mannheim, Germany) in TBST buffer (4.44 g/l Tris–HCL, 2.65 g/l TrisOH, 8.07 g/l NaCl, 0.2 g/l KCl and 500 µl/l Tween-20 in H2O) and subsequently incubated with primary antibody as indicated and horseradish peroxidase-conjugated secondary antibody, anti-mouse or anti-goat IgG (DAKO, Hamburg, Germany), respectively. |
T61 |
2961-3338 |
Sentence |
denotes |
Membranes were blocked with 2.5% blocking reagent (Boehringer Mannheim, Germany) in TBST buffer (4.44 g/l Tris–HCL, 2.65 g/l TrisOH, 8.07 g/l NaCl, 0.2 g/l KCl and 500 µl/l Tween-20 in H2O) and subsequently incubated with primary antibody as indicated and horseradish peroxidase-conjugated secondary antibody, anti-mouse or anti-goat IgG (DAKO, Hamburg, Germany), respectively. |
T3419 |
3339-3447 |
Sentence |
denotes |
The membranes were then developed with an ECL detection kit (Amersham Pharmacia Biotech, Freiburg, Germany). |
T62 |
3339-3447 |
Sentence |
denotes |
The membranes were then developed with an ECL detection kit (Amersham Pharmacia Biotech, Freiburg, Germany). |
T3420 |
3448-3587 |
Sentence |
denotes |
The primary antibodies were goat anti-IRF-4/ICSAT (M-17) (Santa Cruz Biotechnology, Santa Cruz, CA) and mouse anti-β-actin (AC-74) (Sigma). |
T63 |
3448-3587 |
Sentence |
denotes |
The primary antibodies were goat anti-IRF-4/ICSAT (M-17) (Santa Cruz Biotechnology, Santa Cruz, CA) and mouse anti-β-actin (AC-74) (Sigma). |
T4350 |
3589-3631 |
Sentence |
denotes |
Methylation-specific restriction-PCR-assay |
T64 |
3589-3631 |
Sentence |
denotes |
Methylation-specific restriction-PCR-assay |
T4351 |
3632-3696 |
Sentence |
denotes |
DNA was extracted with a commercial kit (Qiagen) as recommended. |
T65 |
3632-3696 |
Sentence |
denotes |
DNA was extracted with a commercial kit (Qiagen) as recommended. |
T4352 |
3697-3940 |
Sentence |
denotes |
Since the restriction ability of several endonucleases is inhibited by methylation of their target sequence, we used methylation-sensitive enzymes HpaII and HaeII-isochizomer Bsp143II and Bsh1236I (MBI Fermentas, St Leon-Rot, Germany) (20,24). |
T66 |
3697-3940 |
Sentence |
denotes |
Since the restriction ability of several endonucleases is inhibited by methylation of their target sequence, we used methylation-sensitive enzymes HpaII and HaeII-isochizomer Bsp143II and Bsh1236I (MBI Fermentas, St Leon-Rot, Germany) (20,24). |
T4353 |
3941-4070 |
Sentence |
denotes |
As control the methylation-resistant enzyme MspI and an enzyme with no recognition site in the target promoter, EcoRI, were used. |
T67 |
3941-4070 |
Sentence |
denotes |
As control the methylation-resistant enzyme MspI and an enzyme with no recognition site in the target promoter, EcoRI, were used. |
T4354 |
4071-4194 |
Sentence |
denotes |
DNA (0.8 µg) was digested by 40 U the respective enzyme for 6 h and, to ensure complete cleavage, additional 20 U for 16 h. |
T68 |
4071-4194 |
Sentence |
denotes |
DNA (0.8 µg) was digested by 40 U the respective enzyme for 6 h and, to ensure complete cleavage, additional 20 U for 16 h. |
T4355 |
4195-4363 |
Sentence |
denotes |
Thereafter 100 ng of digested DNA was used to a PCR amplification of two fragments (F1 and F2) spanning part of the IRF-4 promoter (30) (GenBank U52683; see Figure 3A). |
T69 |
4195-4363 |
Sentence |
denotes |
Thereafter 100 ng of digested DNA was used to a PCR amplification of two fragments (F1 and F2) spanning part of the IRF-4 promoter (30) (GenBank U52683; see Figure 3A). |
T4356 |
4364-4409 |
Sentence |
denotes |
The sequences of the primers were F1-forward: |
T70 |
4364-4409 |
Sentence |
denotes |
The sequences of the primers were F1-forward: |
T4357 |
4410-4502 |
Sentence |
denotes |
5′-TTGAGATGGAGTCTTGCTCTGT-3′, F1-reverse: ATCACTTCCAGACTTCAGTTCACCT-3′ (341 bp); F2-forward: |
T71 |
4410-4502 |
Sentence |
denotes |
5′-TTGAGATGGAGTCTTGCTCTGT-3′, F1-reverse: ATCACTTCCAGACTTCAGTTCACCT-3′ (341 bp); F2-forward: |
T4358 |
4503-4547 |
Sentence |
denotes |
5′-AAGGTGAACTGAAGTCTGGAAGTGA-3′, F2-reverse: |
T72 |
4503-4547 |
Sentence |
denotes |
5′-AAGGTGAACTGAAGTCTGGAAGTGA-3′, F2-reverse: |
T4359 |
4548-4587 |
Sentence |
denotes |
5′-CCAGGACCTCAGGAGGCCAGTCA-3′ (474 bp). |
T73 |
4548-4587 |
Sentence |
denotes |
5′-CCAGGACCTCAGGAGGCCAGTCA-3′ (474 bp). |
T4360 |
4588-4636 |
Sentence |
denotes |
The PCR conditions were described elsewhere (3). |
T74 |
4588-4636 |
Sentence |
denotes |
The PCR conditions were described elsewhere (3). |
T4361 |
4637-4707 |
Sentence |
denotes |
PCR was performed with an annealing temperature of 62°C and 35 cycles. |
T75 |
4637-4707 |
Sentence |
denotes |
PCR was performed with an annealing temperature of 62°C and 35 cycles. |
T4362 |
4708-4908 |
Sentence |
denotes |
When DNA was methylated at specific sites, the sensitive enzymes were not able to digest the DNA and amplification took place; in case of no methylation, DNA was digested and no product was generated. |
T76 |
4708-4908 |
Sentence |
denotes |
When DNA was methylated at specific sites, the sensitive enzymes were not able to digest the DNA and amplification took place; in case of no methylation, DNA was digested and no product was generated. |
T4363 |
4909-5020 |
Sentence |
denotes |
The PCR products were electrophoresed on a 3% agarose gel, were stained with ethidium bromide and photographed. |
T77 |
4909-5020 |
Sentence |
denotes |
The PCR products were electrophoresed on a 3% agarose gel, were stained with ethidium bromide and photographed. |
T4364 |
5021-5072 |
Sentence |
denotes |
PCR products were verified by automated sequencing. |
T78 |
5021-5072 |
Sentence |
denotes |
PCR products were verified by automated sequencing. |
T4932 |
5074-5093 |
Sentence |
denotes |
Bisulfite treatment |
T79 |
5074-5093 |
Sentence |
denotes |
Bisulfite treatment |
T4933 |
5094-5131 |
Sentence |
denotes |
DNA was extracted as described above. |
T80 |
5094-5131 |
Sentence |
denotes |
DNA was extracted as described above. |
T4934 |
5132-5311 |
Sentence |
denotes |
Bisulfite treatment of DNA, leading to conversion of unmethylated cytosine to uracil residues and no change of methylated cytosine residues, was performed as described as follows. |
T81 |
5132-5311 |
Sentence |
denotes |
Bisulfite treatment of DNA, leading to conversion of unmethylated cytosine to uracil residues and no change of methylated cytosine residues, was performed as described as follows. |
T4935 |
5312-5480 |
Sentence |
denotes |
Briefly, 1 µg of DNA and 2 µg of poly(dA–dT)(poly(dA–dT) copolymers (Amersham Pharmacia Biotech) were denaturated for 20 min at 42°C in 0.3 M NaOH in a volume of 50 µl. |
T82 |
5312-5480 |
Sentence |
denotes |
Briefly, 1 µg of DNA and 2 µg of poly(dA–dT)(poly(dA–dT) copolymers (Amersham Pharmacia Biotech) were denaturated for 20 min at 42°C in 0.3 M NaOH in a volume of 50 µl. |
T83 |
5481-5702 |
Sentence |
denotes |
Fresh solutions of 30 µl of 10 mM hydrochinon (Sigma) and 530 µl of 3 M sodium bisulfite (pH 5.0; Sigma) were added, the solution was gently mixed, overlayed with mineral oil and incubated in the dark for 12–13 h at 50°C. |
T4936 |
5481-5803 |
Sentence |
denotes |
Fresh solutions of 30 µl of 10 mM hydrochinon (Sigma) and 530 µl of 3 M sodium bisulfite (pH 5.0; Sigma) were added, the solution was gently mixed, overlayed with mineral oil and incubated in the dark for 12–13 h at 50°C. The aqueous phase was recovered using the ‘Wizard DNA clean-up system’ (Promega, Mannheim, Germany). |
T84 |
5703-5803 |
Sentence |
denotes |
The aqueous phase was recovered using the ‘Wizard DNA clean-up system’ (Promega, Mannheim, Germany). |
T4937 |
5804-5960 |
Sentence |
denotes |
The purified DNA was subsequently mixed with 1 M NaOH to a final concentration of 0.3 M and incubated for 20 min at 37°C to ensure complete desulfonisation. |
T85 |
5804-5960 |
Sentence |
denotes |
The purified DNA was subsequently mixed with 1 M NaOH to a final concentration of 0.3 M and incubated for 20 min at 37°C to ensure complete desulfonisation. |
T4938 |
5961-6094 |
Sentence |
denotes |
DNA was ethanol precipitated in the presence of 1/10 vol of 3 M sodium acetate, washed with 70% ethanol and resuspended in 50 µl H2O. |
T86 |
5961-6094 |
Sentence |
denotes |
DNA was ethanol precipitated in the presence of 1/10 vol of 3 M sodium acetate, washed with 70% ethanol and resuspended in 50 µl H2O. |
T4939 |
6095-6310 |
Sentence |
denotes |
Subsequent PCR amplification of 4 µl bisulfite-treated DNA was used for cloning of two fragments of the IRF-4 promoter (BS-I and BS-II) into pCR2.1 vector with the ‘TOPO TA cloning kit’ (Invitrogen) (see Figure 3A). |
T87 |
6095-6310 |
Sentence |
denotes |
Subsequent PCR amplification of 4 µl bisulfite-treated DNA was used for cloning of two fragments of the IRF-4 promoter (BS-I and BS-II) into pCR2.1 vector with the ‘TOPO TA cloning kit’ (Invitrogen) (see Figure 3A). |
T4940 |
6311-6734 |
Sentence |
denotes |
The primers used for PCR amplification of the BS-I and BS-II fragments contain the putative altered sequence of the sense strand due to bisulfite treatment (converted cytosine residues are written in bold letters): BS-I-forward 5′-TATTTGGATTTTTAGGGAGTTTTTTTT-3′, BS-I-reverse 5′-ACCCAACTCCCTTAAACTATTAAACT-3′ (187 bp); BS-II-forward 5′-AGTTTAATAGTTTAAGGGAGTTGGGT-3′, BS-II-reverse 5′-CTCACCCTAAACTCAAAACTAAAAAC-3′ (674 bp). |
T88 |
6311-6734 |
Sentence |
denotes |
The primers used for PCR amplification of the BS-I and BS-II fragments contain the putative altered sequence of the sense strand due to bisulfite treatment (converted cytosine residues are written in bold letters): BS-I-forward 5′-TATTTGGATTTTTAGGGAGTTTTTTTT-3′, BS-I-reverse 5′-ACCCAACTCCCTTAAACTATTAAACT-3′ (187 bp); BS-II-forward 5′-AGTTTAATAGTTTAAGGGAGTTGGGT-3′, BS-II-reverse 5′-CTCACCCTAAACTCAAAACTAAAAAC-3′ (674 bp). |
T4941 |
6735-6926 |
Sentence |
denotes |
After bacterial amplification of the cloned PCR fragments by standard procedures, eight clones from each sample were sequenced with an automated sequencer (ABI Prism 377, Applied Biosystems). |
T89 |
6735-6926 |
Sentence |
denotes |
After bacterial amplification of the cloned PCR fragments by standard procedures, eight clones from each sample were sequenced with an automated sequencer (ABI Prism 377, Applied Biosystems). |
T5684 |
6928-6973 |
Sentence |
denotes |
In vitro methylation and reporter gene assays |
T90 |
6928-6973 |
Sentence |
denotes |
In vitro methylation and reporter gene assays |
T91 |
6974-7046 |
Sentence |
denotes |
The IRF-4 promoter-reporter gene construct was generously provided by J. |
T5685 |
6974-7060 |
Sentence |
denotes |
The IRF-4 promoter-reporter gene construct was generously provided by J. Hiscott (31). |
T92 |
7047-7060 |
Sentence |
denotes |
Hiscott (31). |
T5686 |
7061-7248 |
Sentence |
denotes |
Constructs were methylated in vitro with CpG Methylase (M.Sss I) as recommended by the manufacturer (NE Biolabs) and complete methylation was checked via restriction analysis (Figure 5A). |
T93 |
7061-7248 |
Sentence |
denotes |
Constructs were methylated in vitro with CpG Methylase (M.Sss I) as recommended by the manufacturer (NE Biolabs) and complete methylation was checked via restriction analysis (Figure 5A). |
T5687 |
7249-7360 |
Sentence |
denotes |
Reporter gene assays using the dual luciferase assay (Promega) were performed similar to previous reports (29). |
T94 |
7249-7360 |
Sentence |
denotes |
Reporter gene assays using the dual luciferase assay (Promega) were performed similar to previous reports (29). |
T5688 |
7361-7528 |
Sentence |
denotes |
Briefly, 5 nM of the reporter construct and the transfection control construct expressing the renilla luciferase gene were transientlyco-expressed via electroporation. |
T95 |
7361-7528 |
Sentence |
denotes |
Briefly, 5 nM of the reporter construct and the transfection control construct expressing the renilla luciferase gene were transientlyco-expressed via electroporation. |
T5689 |
7529-7611 |
Sentence |
denotes |
The control construct served as an internal reference for transfection efficiency. |
T96 |
7529-7611 |
Sentence |
denotes |
The control construct served as an internal reference for transfection efficiency. |
T5690 |
7612-7747 |
Sentence |
denotes |
Forty-eight hours after transfection, luciferase activity was measured with a LB 96 P microlumat (EG&G Berthold, Bad Wildbad, Germany). |
T97 |
7612-7747 |
Sentence |
denotes |
Forty-eight hours after transfection, luciferase activity was measured with a LB 96 P microlumat (EG&G Berthold, Bad Wildbad, Germany). |
T5691 |
7748-7864 |
Sentence |
denotes |
IRF-4 promoter activation was quantified as a ratio of measured firefly light units (flu) relative to renilla (rlu). |
T98 |
7748-7864 |
Sentence |
denotes |
IRF-4 promoter activation was quantified as a ratio of measured firefly light units (flu) relative to renilla (rlu). |
T5692 |
7865-7918 |
Sentence |
denotes |
Each experiment was carried out at least three times. |
T99 |
7865-7918 |
Sentence |
denotes |
Each experiment was carried out at least three times. |